MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back

References

• Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24), 15524–15529 (2002).
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A et al. A Micro-RNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353(17), 1793–1801 (2005).
   PubMed Web of Science ®Google Scholar
• Klein U, Lia M, Crespo M et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17(1), 28–40 (2010).
   PubMed Web of Science ®Google Scholar
• Lochmanova J, Navrkalova V, Dvorakova B et al. Micro-RNA mutational analysis in patients with chronic lymphocytic leukemia. Presented at: XIV. International Workshop on Chronic Lymphocytic Leukemia, Houston, TX, USA, 28–30 October 2011.
   Google Scholar
• Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. Micro-RNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk. Lymphoma 50(3), 506–509 (2009).
   PubMed Web of Science ®Google Scholar
• ChenL, CuiB, ChenG, SalcedoM, Croce MC, KippsTJ. miR-155 contributed to chronic lymphocytic leukemia survival by modulation of BCR-signalling. Presented at: ASH Annual Meeting and Exposition, San Diego, CA, USA, 10–13 December 2011.
   Google Scholar
• Li S, Moffett HF, Lu J et al. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS ONE 6(3), e16956 (2011).
   PubMed Web of Science ®Google Scholar
• Costinean S, Zanesi N, Pekarsky Y et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA 103(18), 7024–7029 (2006).
   PubMed Web of Science ®Google Scholar
• Vargova K, Curik N, Burda P et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 117(14), 3816–3825 (2011).
   PubMed Web of Science ®Google Scholar
• Mraz M, Dolezalova D, Plevova K et al. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood 119(9), 2110–2113 (2012).
   PubMed Web of Science ®Google Scholar
• PapakonstantinouN, NtoufaS, PapadopoulosG, HatzigeorgiouA, AnagnostopoulosA, StamatopoulosK. Distinct profiles of miRNAs modulating immune signaling pathways in different subsets of chronic lymphocytic leukemia. Presented at: EHA Annual Meeting, Amsterdam, The Netherlands, 14–17 June 2012.
   Google Scholar
• Mraz M, Malinova K, Kotaskova J et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 23(6), 1159–1163 (2009).
   PubMed Web of Science ®Google Scholar
• Zenz T, Mohr J, Eldering E et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 113(16), 3801–3808 (2009).
   PubMed Web of Science ®Google Scholar
• Asslaber D, Piñón JD, Seyfried I et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 115(21), 4191–4197 (2010).
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP et al. A microRNA component of the p53 tumour suppressor network. Nature 447(7148), 1130–1134 (2007).
   PubMed Web of Science ®Google Scholar
• Mraz M, Cerna K, Mayerova V et al. MicroRNA-34a as a marker for fludarabine resistance and impairment of p53-pathway in chronic lymphocytic leukemia. Presented at: ASH Annual Meeting, Atlanta, GA, USA, 8–11 December 2012.
   Google Scholar
• Fabbri M, Bottoni A, Shimizu M et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305(1), 59–67 (2011).
   PubMed Web of Science ®Google Scholar
• Pallasch CP, Patz M, Park YJ et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 114(15), 3255–3264 (2009).
   PubMed Web of Science ®Google Scholar
• Sampath D, Calin GA, Puduvalli VK et al. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 113(16), 3744–3753 (2009).
   PubMed Web of Science ®Google Scholar
• Baer C, Claus R, Frenzel LP et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 72(15), 3775–3785 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Roccaro AM, Rombaoa C et al. LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas. Blood 120(8), 1678–1686 (2012).
   PubMed Web of Science ®Google Scholar